Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer by Teo, M, Dyrskjøt, L, Nsengimana, J, Buchwald, C, Snowden, H, Morgan, J, Jensen, J, Knowles, M, Taylor, G, Barrett, J, Borre, M, Orntoft, T, Bishop, D, Kiltie, A

GABA regulates electrical activity and tumor initiation in melanoma by Tagore, M, Hergenreder, E, Perlee, SC, Cruz, NM, Menocal, L, Suresh, S, Chan, E, Baron, M, Melendez, S, Dave, A, Chatila, WK, Nsengimana, J, Koche, RP, Hollmann, TJ, Ideker, T, Studer, L, Schietinger, A, White, RM

Tumour gene expression signature in primary melanoma predicts long-term outcomes by Garg, M, Couturier, D-L, Nsengimana, J, Fonseca, NA, Wongchenko, M, Yan, Y, Lauss, M, Jönsson, GB, Newton-Bishop, J, Parkinson, C, Middleton, MR, Bishop, T, Sarah, M, Stefanos, N, Tadross, J, Vergara, IA, Lo, S, Felicity, N, Wilmott, JS, Thompson, JF, Long, GV, Scolyer, RA, Corrie, P, Adams, DJ, Brazma, A, Rabbie, R